Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-28

Clinical Trial Update: Study to Evaluate Using Nelfinavir With Chemoradiation for Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating nelfinavir with chemoradiation for non-small cell lung cancer was terminated, and results were posted in 2017. The sponsor was the Un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nelfinavir (nelfinavir)

Snippet

Sponsor: University of Iowa | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: TERMINATED | Results posted: 2017-07-28